Please login to the form below
online portal
This page shows the latest online portal news and features for those working in and with pharma, biotech and healthcare.
EFPIA pledges to boost drug access throughout Europe
Consequently, the commitment to file is supported by the launch of an online portal where marketing authorisation holders can provide timely information regarding the processing of pricing and reimbursement applications in
Latest news
-
Communiqué Awards 2021 – extended entry deadline is 18 March!
Entries can be submitted via the online entry system, newly designed to streamline the entry process by enabling entrants to have complete control over their entries. ... The online portal also includes clear instructions on what needs to be included in
-
Communiqué Awards 2021 entry deadline is two weeks away!
With only two weeks until the Comm uniqué Awards 2021 entry deadline on 11 March, make sure you check out the new online entry portal and start working on your submissions ... now. The online entry portal – brand new for 2021 – can be accessed via
-
Communiqué Awards 2021 are open for entry!
Newly introduced online entry system is accepting entries. The Comm uniqué Awards 2021 are now open for entry, with a new online entry system that will help to streamline the entry ... The online portal also includes clear instructions on what needs to
-
IQVIA launches new online patient portal
The IQVIA Patient Portal focuses on increasing clinical trial patient recruitment, engagement and retention by ensuring transparency and collaboration at all stages of the clinical trial process. ... Clinical trial participants are invited to join the
-
Clinical trial ‘High Throughput Centres’ could help UK compete post-Brexit
A new online EU clinical trial portal will allow sponsors of trials involving multiple sites to submit a single application for multiple sites to authorities of all EU Member States.
More from news
Approximately 1 fully matching, plus 28 partially matching documents found.
Latest Intelligence
-
Achieving insight
Whether it be an app, an online HCP portal, or an information leaflet, people use and interact with things in different ways.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Digital Opinion Leaders (DOLs): Who are they and how can Pharma engage them?
Examples of projects that benefit from DOL involvement include:. 1. Online advisory boards and insight-gathering. ... Giving them access to a safe, secure, and compliant online portal where they can share best practices and collaborate on projects can
-
Top 10 Most Common Participant Comments - Online Advisory Boards
At the end of each asynchronous (over-time, anytime) touchpoint, we always survey the participants to gather their feedback on the online portal user experience, tools, and interactivity.
-
Site-related factors that can impact patient recruitment
A patient portal is a secure, online platform that gives patients 24-hour access to health information, such as their current medications, lab results, discharge summaries, and much more. ... By setting up a patient portal for you study and making sure
-
Improving patient retention with the use of patient portals
A patient portal is a secure, online platform that gives you and your patients 24-hour access to health information, such as your patient’s current medications, lab results, discharge summaries, ... So, let’s take a closer look into five benefits of
-
Blue Latitude Health wins PMEA 2015 Innovation award
The Medical Information Cascade project combined SEO tactics, user-centred design methodologies, and the provision of capability training to deliver a first line medical information portal online – the first of its ... HCPs can get the information
More from PMHub
Approximately 1 fully matching, plus 8 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- Sanofi halts recruitment for trials assessing MS treatment
- bluebird bio reveals plans to launch two gene therapies
- AstraZeneca and Daiichi Sankyo receive FDA approval for lung cancer drug
- ONS data reveals significant decrease in COVID-19 antibodies
- Bristol Myers Squibb and GentiBio in $1.9bn deal to develop IBD therapies
- UK government’s ‘science superpower’ ambitions to fail without clear plan, Lords committee warns
- WHO releases interim statement on COVID-19 vaccination for children and adolescents
- Novartis reports death of two patients treated with Zolgensma
- The impact of COVID-19 on the fight against AMR
- NHS bowel cancer checks reach record-high following death of Dame Deborah James
- Environment: where does the pharmaceutical industry stand?
- Moderna’s Omicron booster receives MHRA approval
- Sanofi halts recruitment for trials assessing MS treatment
- BeiGene announces positive phase 3 trial results for liver cancer treatment
- Amgen acquires ChemoCentryx in $3.7bn cash deal
- A creative awakening – how pharma is bringing innovation to the patient journey
- Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
- AbbVie and Sosei Heptares collaborate in new agreement worth up to $1.2bn
PMHub
Origins Insights
Origins are part of the Resonant Group. Using novel research methodologies, we dig deeper to deliver authentic audience experiences that...
Latest intelligence
- Environment: where does the pharmaceutical industry stand?
- ...
- The communication challenge of helping he next generation to be healthier
- As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
- Are we losing sight of what the democratisation of healthcare really looks like?
- We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
